Hidradenitis suppurativa (HS) treatment has drastically changed in the last 15 years with FDA-approved biologics and an understanding of the need for comprehensive care that addresses the multifactorial pathogenesis of…
Read More
Leaves are falling and nights are getting longer — fall is here. Even if summer felt like it went by in a blink, it's important not to miss developments in…
Read More
The August issue of Dermatology Times featured an article written by dermatologist Darrell Rigel, MD, FAAD, about his 2025 Journal of Drugs in Dermatology study on dermatology clinician perspectives on…
Read More
Healio featured two Journal of Drugs in Dermatology studies in recent articles, including an article on UV light as an underappreciated workplace hazard. The study, "Sun Exposure and Cancer Outcomes…
Read More
MedPage Today/Dermatology World Weekly highlighted a Journal of Drugs in Dermatology study comparing a topical JAK inhibitor with a common topical steroid in atopic dermatitis (AD). The study, “Ruxolitinib Cream…
Read More
Nail Toxicities with FGFR Inhibitors — A JDD Systematic Review Worth Reading Have you read this article from the March 2026 issue of JDD? A systematic review covering reports through…
Read More
Dermatology Times highlighted three Journal of Drugs in Dermatology studies in recent articles, including an examination of “fungal acne.” In the study, “Malassezia Folliculitis Presentation, Diagnosis, and Treatment: A Review…
Read More
Physician’s Weekly interviewed dermatologist Geeta Yadav, MD, for her perspective on the March Journal of Drugs in Dermatology study, “Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.”…
Read More
Survey reveals higher likelihood of reported delays in accessing melanoma care among patients with skin of color The National Psoriasis Foundation (NPF) has a new position statement that clarifies the…
Read More
Medscape highlighted a January Journal of Drugs in Dermatology study on the incidence of skin and hair effects from GLP-1 agonists. The study, “Cutaneous Adverse Events Associated With GLP-1 Receptor…
Read More
Medscape featured a December Journal of Drugs in Dermatology study on the link between isotretinoin and inflammatory bowel disease (IBD). The study, “Isotretinoin Does Not Increase the Risk of Inflammatory…
Read More
Healio profiled a July Journal of Drugs in Dermatology study on the affordability of dermatologist-recommended skincare products for atopic dermatitis. The study, “Socioeconomic Disparities in Gentle Skin Care Access for…
Read More
